Restart Life Sciences Advances Holy Crap Foods Protein Products to Pre-Production Stage in Partnership with University of Manitoba RCFTR

Company Overview: Restart Life Sciences and Holy Crap Foods

Restart Life Sciences Corp., headquartered in Vancouver, British Columbia, is a Canadian life sciences company listed on the Canadian Securities Exchange (CSE: HEAL), Frankfurt Stock Exchange (FSE: HN30), and OTC Pink (NMLSF). More information is available at www.restartlife.co.

Holy Crap Foods Inc., a fully owned subsidiary of Restart Life Sciences, operates as a premium functional food brand specializing in organic, superseed-based breakfasts and oatmeals. Utilizing certified organic ingredients such as chia, hemp, and buckwheat, Holy Crap Foods targets health-conscious North American consumers seeking gut health, clean digestion, and sustained energy without artificial additives. The brand is positioned within the functional wellness and plant-based nutrition markets.

University of Manitoba RCFTR’s Role in Product Development

The Richardson Centre for Food Technology and Research (RCFTR) at the University of Manitoba provided critical food science expertise supporting the profiling and development of plant-based protein formulations for Holy Crap Foods. The RCFTR team completed research on the core protein line, enabling its progression to pre-production.

The collaboration focused on commercial objectives, integrating research insights into the SKU framework for Holy Crap Foods. Outputs from the partnership are guiding the development of the kids and seniors nutritional product extensions.

Core Protein Line Progresses to Pre-Production

Restart Life Sciences confirmed that its core protein formulations have passed key testing milestones and moved beyond the conceptual stage. The manufacturing team is now engaged in final pre-production scaling and quality assurance, marking the transition toward commercial production.

While production finalization is underway, the company did not provide specific timelines, volume targets, financial projections, or details on production costs and capital requirements.

Development of Kids and Seniors Nutritional SKUs

In addition to the core protein line, two new functional food verticals are in active development. The first targets the premium youth and kids breakfast market with a low-sugar, clean-label product. The second focuses on geriatric and seniors nutrition, emphasizing digestive health and cognitive wellness.

These verticals are described as "high-growth functional food segments," though no market size or revenue forecasts were included. Details on SKU counts, pricing, or distribution channels were not disclosed. Development builds upon the core protein line milestone.

CEO Steve Loutskou Comments on Milestone

CEO Steve Loutskou stated: "Integrating top-tier research into scalable commercial products is central to our strategy. Our partnership with the University of Manitoba’s food sciences department has allowed us to embed science-backed insights into our SKU framework. Advancing to pre-production brings us closer to launching these specialized products. We are finalizing production frameworks and look forward to market introduction soon."

His remarks reinforce the operational update without revealing financial targets, launch dates, or distribution agreements.

Alignment with Product Development Roadmap

The announcement references a recently disclosed product development roadmap aimed at leveraging emerging consumer shopping trends. The RCFTR collaboration’s results are integrated into upcoming formulations aligned with this roadmap. The pre-production advancement is consistent with the company’s milestone execution.

No further details on the roadmap or consumer trends were provided. Restart Life Sciences remains focused on growth strategy execution, sustainable revenue generation, and geographic and demographic expansion, though no specific expansion targets were mentioned.

Holy Crap Foods in the Plant-Based and Functional Food Market

Holy Crap Foods operates within the growing plant-based and functional food sector, which has gained notable consumer and retail interest in North America. Its certified organic superseed-based products—featuring chia, hemp, and buckwheat—are free from artificial additives and emphasize gut health and clean digestion. While no market data was cited, these attributes align with increasing consumer demand.

The development of kids and seniors nutritional lines expands the brand’s demographic reach beyond health-conscious adults. The low-sugar, clean-label kids products and digestive and cognitive wellness-focused seniors products reflect recognized nutritional priorities in these groups. The company did not disclose clinical validation, regulatory status, or health claim approvals in this announcement.

Corporate Strategy Focused on Sustainable Growth

Restart Life Sciences emphasizes its commitment to executing its growth strategy, driving sustainable revenue, and expanding into new markets. The company frames these commercialization efforts as foundational to creating long-term corporate value. These forward-looking statements are subject to risks and uncertainties outlined in the release.

Shareholders were thanked for their ongoing support. No financial results, revenue figures, or operational metrics were disclosed.

Stock Listings and Market Information

Restart Life Sciences Corp. is publicly traded on the Canadian Securities Exchange (HEAL), Frankfurt Stock Exchange (HN30), and OTC Pink (NMLSF). The company is incorporated in Canada with headquarters in Vancouver, British Columbia. This update was issued on July 14, 2026, from Vancouver.

Immediate market reaction was unclear at the time of reporting. The Canadian Securities Exchange and its Market Regulator disclaim responsibility for the accuracy or adequacy of the release.

Forward-Looking Statements and Risks

The release contains forward-looking statements under Canadian securities laws, including intentions to move formulations into commercial production, launch specialized SKUs, and expand markets. It acknowledges risks and uncertainties that could cause actual results to differ materially from expectations.

Such statements are identified by terms like "expects," "plans," "anticipates," "believes," "intends," "estimates," "projects," "potential," "strategy," "expansion," "launch," and similar conditional language. Readers are advised to consult the company’s regulatory filings for a comprehensive discussion of risk factors.